Non-invasive blood-glucose monitoring
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Growth Berlin medtech DiaMonTech (non-invasive blood-glucose measurement) closed an EUR 8M follow-on round led by Companisto, with Samsung Next and institutional investors. | $8.7M |
| Dec 2023 | Funding round Berlin medtech DiaMonTech raised an undisclosed seven-figure sum from family office Moll Family for its non-invasive glucose monitoring. | — |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.